Abvc BiopharmaABVC
13F holders, Q2 2026 (June 30)15holders +2
7new positions
5sold out
1famous investor
$1.58avg. 13F price*
At the end of Q2 2026, 15 institutions reported holding Abvc Biopharma Inc. (ABVC) in their 13F filings, up 2 from Q1 2026. 7 opened new positions and 5 sold out. The largest holders were Vanguard Capital Management LLC ($592K), Geode Capital Management, LLC ($360K) and Vanguard Fiduciary Trust Co. ($154K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Abvc Biopharma Inc.
- CUSIP
- 00091F304
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $281K |
| Exits | 5 | $140K |
All 13F filers, Q1 2026 → Q2 2026: 417,660 shares bought and 144,320 shares sold, net +273,340 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Vanguard Capital Management LLC | 0.00% | Add +96.5% | 374,499 | $592K |
| Geode Capital Management, LLC | 0.00% | Add +3.1% | 228,042 | $360K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 97,363 | $154K |
| State Street Corp. | 0.00% | No change | 72,800 | $115K |
| Citadel Advisors | 0.00% | New | 72,091 | $114K |
| BlackRock, Inc. | 0.00% | No change | 56,442 | $89K |
| Northern Trust Corp. | 0.00% | Add +51.6% | 48,643 | $77K |
| XTX Topco Ltd | 0.00% | New | 48,276 | $76K |
| Panagora Asset Management Inc. | 0.00% | New | 36,682 | $58K |
| UBS Group AG | 0.00% | Add +1826.8% | 34,123 | $54K |
| Jane Street Group, LLC | 0.00% | New | 20,059 | $32K |
| Citigroup Inc. | 0.00% | New | 540 | $853 |
| LifeSteps Financial, Inc. | 0.00% | New | 300 | $474 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 6 | $9 |
| Royal Bank of Canada | 0.00% | No change | 17 | $0 |
"% of holder's portfolio" is ABVC's weight in each manager's 13F, not the share of Abvc Biopharma Inc. the manager owns.